Jim Cramer Isn't Sure If There’s Upside In This Health Care Stock
Cramer favors Howmet, remains cautious on AeroVironment, Rocket, AtaiBeckley and MP Materials, citing competition and limited upside.
Stocks · News reference
Benchmark Maintains Buy on Rocket Companies, Lowers Price Target to $19
Benchmark analyst Daniel Kurnos maintains Rocket Companies (NYSE:RKT) with a Buy and lowers the price target from $21 to $19.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Reported Earlier, Redfin Reaches Resolution With FTC And Five States, Retaining $100 Million From Original Zillow Syndication Agreement Signed February 2025
8-K filing — Rocket Companies, Inc. (RKT)
Filed: 2026-08-17 AccNo: 0001628280-26-057366 Size: 158 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
RBC Capital Maintains Sector Perform on Rocket Companies, Raises Price Target to $16
RBC Capital analyst Daniel R. Perlin maintains Rocket Companies (NYSE:RKT) with a Sector Perform and raises the price target from $15 to $16.